Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging.
Andrew EvansRubina M TrimboliAlexandra AthanasiouCorinne BalleyguierPascal A BaltzerUlrich BickJulia Camps HerreroPaola ClauserCatherine ColinEleanor CornfordEva M FallenbergMichael H FuchsjaegerFiona J GilbertThomas H HelbichKaren KinkelSylvia H Heywang-KöbrunnerChristiane K KuhlRitse M MannLaura MartincichPietro PanizzaFederica PediconiRuud M PijnappelKatja PinkerSophia ZackrissonGabor ForraiFrancesco Sardanellinull nullPublished in: Insights into imaging (2018)
• US is an established tool for suspected cancers at all ages and also the method of choice under 40. • For US-visible suspicious lesions, US-guided biopsy is preferred, even for palpable findings. • High-risk women can be screened with US, especially when MRI cannot be performed. • Supplemental US increases cancer detection but also false positives, biopsy rate and follow-up exams. • Breast US is inappropriate as a stand-alone screening method.
Keyphrases
- polycystic ovary syndrome
- ultrasound guided
- fine needle aspiration
- magnetic resonance imaging
- primary care
- high resolution
- pregnancy outcomes
- cervical cancer screening
- pulmonary embolism
- healthcare
- squamous cell
- clinical practice
- magnetic resonance
- insulin resistance
- adipose tissue
- mass spectrometry
- skeletal muscle
- quantum dots
- childhood cancer
- decision making
- social media
- photodynamic therapy